GreenLab Partners With Ginkgo Bioworks To Scale Up Production Of Brazzein, A Novel Sweetener
Portfolio Pulse from Benzinga Newsdesk
GreenLab has announced a partnership with Ginkgo Bioworks to increase the production of Brazzein, a new sweetener. This collaboration aims to leverage Ginkgo Bioworks' biotechnology expertise to scale up the manufacturing process of Brazzein, which is known for its high sweetness level and low-calorie content, making it a promising alternative to traditional sugar and artificial sweeteners.
May 07, 2024 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ginkgo Bioworks' partnership with GreenLab to scale up Brazzein production could significantly impact its business, potentially increasing revenue streams and enhancing its reputation in the biotech industry.
The partnership with GreenLab to increase the production of Brazzein positions Ginkgo Bioworks at the forefront of biotechnological innovation in the food industry. This collaboration not only opens up new revenue opportunities for Ginkgo Bioworks but also enhances its reputation as a leader in leveraging biotechnology for sustainable and health-conscious solutions. Given the growing demand for healthier sweetener alternatives, this partnership is likely to have a positive short-term impact on Ginkgo Bioworks' stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90